Long-term nephrotoxicity in irradiated pediatric kidney tumor survivors: A systematic review.
childhood
kidney failure
kidney tumor
nephrotoxicity
radiotherapy
Journal
Pediatric blood & cancer
ISSN: 1545-5017
Titre abrégé: Pediatr Blood Cancer
Pays: United States
ID NLM: 101186624
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
revised:
01
08
2023
received:
20
09
2022
accepted:
02
08
2023
medline:
26
9
2023
pubmed:
10
8
2023
entrez:
10
8
2023
Statut:
ppublish
Résumé
Nephrotoxicity can occur as a side effect after treatment for kidney tumor in childhood. The use of radiotherapy (RT) has a potential additional effect. A systematic electronic literature search that combined childhood kidney cancer with different treatments and nephrotoxicity terms was performed in EMBASE. Studies were included based on the reporting of nephrotoxicity occurrence after treatment for kidney tumor during pediatric age, with 75% of participants being under the age of 25 years at the time of diagnosis, and having been treated with any type of kidney surgery, chemotherapy, and/or RT. A pooled analysis did not show significant difference in estimated glomerular filtration rate between the group of patients who received RT compared with the group treated without RT (SMD -0.11 [95% CI -1.07-0.84] p = .733). The current literature suggests that the use of RT does not have a significant impact on the decline of kidney function as independent factor.
Types de publication
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e30624Informations de copyright
© 2023 The Authors. Pediatric Blood & Cancer published by Wiley Periodicals LLC.
Références
Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1975-2001. National Cancer Institute. Bethesda, MD; 2004. Accessed January 17, 2022. https://seer.cancer.gov/csr/1975_2001/
Constine LS, Tarbell NJ, Halperin NC. Pediatric Radiation Oncology. Lippincott Williams and Wilkins Philadelphia. 6th ed. 2016.
Breslow N, Olshan A, Beckwith JB, Green DM. Epidemiology of Wilms tumor. Med Pediatr Oncol. 1993;21:172.
Van den Heuvel-Eibrink MM, Hol JA, Pritchard-Jones K, et al. Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol. Nat Rev Urol. 2017;14:743-752.
Dix D, Seibel NL, Chi YY, et al. Treatment of stage IV favorable histology Wilms Tumor with lung metastases: a Report From the Children's. Oncology Group AREN0533 Study J Clin Oncol. 2018;36:1564-1570.
Verschuur A, Van Tinteren H, Graf N, et al. Treatment of pulmonary metastasis in children with stage IV nephroblastoma with risk-based use of pulmonary radiotherapy. J Clin Oncol. 2012;30(9):980-988.
Irtan S, Ehrlich PF, Pritchard-Jones K. Wilms tumor: “State-of-the-art” update, 2016. Semin Pediatr Surg. 2016;25:250-256.
Warmann SW, Furtwängler R, Blumenstock G, et al. Tumor biology influences the prognosis of nephroblastoma patients with primary pulmonary metastases: results from SIOP 93-01/GPOH and SIOP 2001/GPOH. Ann Surg. 2011;254(1):155-162.
Dome JS, Cotton CA, Perlman EJ, et al. Treatment of anaplastic histology Wilms’ Tumor: results from the Fifth National Wilms’ Tumor Study. J Clin Oncol. 2006;24:2352-2358.
Gooskens SL, Graf N, Furtwängler R, et al. Rationale for the treatment of children with CCSK in the UMBRELLA SIOP- RTSG 2016 protocol. Nat Rev Urol. 2018;15:309-319.
Furtwängler R, Gooskens SL, Van Tinteren H, et al. Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group. Eur J Cancer. 2013;49:3497-3506.
Gooskens SL, Furtwängler R, Vujanic GM et al. Clear cell sarcoma of the kidney: A review. Eur J Cancer 2012;28:2219-2226.
Van den Heuvel-Eibrink MM, van Tinteren H, Rehorst H, et al. Malignant Rhabdoid Tumours of the Kidney (MRTK), registered on recent SIOP protocols from 1993 to 2005: A report of the SIOP Renal Tumour Study Group. Pediatr Blood Cancer 2011;56:733-737.
Van Dijk I, Oldenburger F, Cardous-Ubbink MC Geenen MM, et al. Evaluation of late adverse events in long-term Wilms’ tumor survivors. Int J Radiat Oncol Biol Phys. 2010;78:370-378.
Geenen MM, Cardous-Ubbink MC, Kremer LCM, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA. 2007;297:2705-2715.
Oeffinger KC, Mertens AC, Sklar CA, et al. Childhood Cancer Survivor Study: chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355:1572-1582.
Kooijmans ECM, Bokenkamp A, Tjahjadi NS, et al. Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer. Cochrane Database Syst Rev. 2019;3(3):CD008944.
Skinner R, Parry A, Price L, et al. Glomerular toxicity persists 10 years after ifosfamide treatment in childhood and is not predictable by age or dose. Pediatr Blood Cancer. 2010;54:983-989.
Oberlin O, Fawaz O, Rey A, et al. Long-term evaluation of ifosfamide related nephrotoxicity in children. J Clin Oncol. 2009;27:5350-5355.
Aronson D, Slaar A, Heinen RC, et al. Long-term outcome of bilateral Wilms tumors (BWT). Pediatr Blood Cancer. 2011;56:1110-1113.
Cozzi DA, Ceccanti S, Cozzi F. Renal function up to the 5th decade of life after nephrectomy in childhood: a literature review. Nephrology (Carlton). 2018;23:397-404.
Dekkers IA, Blijdorp K, Cransberg K, et al. Long-term nephrotoxicity in adult survivors of childhood cancer. Clin J Am Soc Nephrol. 2013;8(6):922-929.
Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52:377-384.
Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for Reporting Observational Studies. Ann Intern Med. 2007;147:573-577.
Higgins JPT, Lane PW, Anagnostelis B, et al. A tool to assess the quality of a meta-analysis. Res Syn Methods. 2013;4:351-366.
Bailey S, Roberts A, Brock C, et al. Nephrotoxicity in survivors of Wilms’ tumours in the North of England. Br J Cancer. 2002;87:1092-1098.
Neu MA, Russo A, Wingerter A, et al. Prospective analysis of long-term renal function in survivors of childhood Wilms tumor. Pediatr Nephrol. 2017;32:1915-1925.
Sánchez Sánchez A, Girón Vallejo O, Ruiz Pruneda R, et al. Función renal a largo plazo en supervivientes de tumor de Wilms. Cir Pediatr. 2019;32:86-92.
Schiavetti A, Altavista P, De Luca L, et al. Long-term renal function in unilateral non-syndromic renal tumor survivors treated according to International Society of Pediatric Oncology protocols. Pediatr Blood Cancer. 2015;62:1637-1644.
Daw NC, Gregornik D, Rodman J, et al. Renal function after ifosfamide, carboplatin, and etoposide (ICE) chemotherapy, nephrectomy, and radiotherapy in children with Wilms tumour. Eur J Cancer. 2009;45(1):99-106.
Makipernaa A, Koskimies O, Jaaskelainen J, et al. Renal growth and function 11-28 years after treatment of Wilms' tumour. Eur J Pediatr. 1991;150:444-447.
Kostel Bal AS, Yalcın B, Susam-Sen H, et al. Renal late effects after the treatment of unilateral nonsyndromic Wilms tumor. J Pediatr Hematol Oncol. 2016;38:e147-e150.
Green DM, Wang M, Krasin M, et al. Long-term renal function after treatment for unilateral, non-syndromic Wilms tumor. A report from the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer. 2020;67:e28271.
Kern AJM, Inouye B, Ko JS, et al. Impact of nephrectomy on long-term renal function in non-syndromic children treated for unifocal Wilms tumor. J Pediatr Urol. 2014;10:662.
Mavinkurve-Groothuis AMC, van de Kracht F, Westland R, van Wijk JAE, Loonen JJ, Schreuder MF. Long-term follow-up of blood pressure and glomerular filtration rate in patients with a solitary functioning kidney: a comparison between Wilms tumor survivors and nephrectomy for other reasons. Pediatr Nephrol. 2016;31:435-441.
Knijnenburg SL, Mulder RL, Schouten-Van Meeteren AYN, et al. Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer (Review). Cochrane Database of Syst Rev. 2013;10:CD008944.
Bardi E, Olah AV, Bartyik K, et al. Late effects on renal glomerular and tubular function in childhood cancer survivors. Pediatr Blood Cancer. 2004;43:668-673.
Breslow NE, Collins AJ, Ritchey ML, et al. End-stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the united states renal data system. J Urol. 2005;174:1972-1975.
Igaki H, Karasawa K, Sakamaki H, et al. Renal dysfunction after total-body irradiation. Significance of selective renal shielding blocks. Strahlenther Onkol. 2005;181:704-708.
Cohen EP. Radiation nephropathy after bone marrow transplantation. Kidney Int. 2000;58:903-918.
Moulder JE, Fish BL. Late toxicity of total body irradiation with bone marrow transplantation in a rat model. Int J Radiat Oncol Biol Phys. 1989;16:1501-1509.
Cohen EP, Fish BL, Moulder JE. Mitigation of radiation injuries via suppression of the renin-angiotensin system: emphasis on radiation nephropathy. Curr Drug Targets. 2010;11:1423-1429.
Edeani A, Cohen EP, Chapter 10. The American Society of Nephrology 2016. Accessed December 06, 2021. www.asn-online.org/education/distancelearning/curricula/onco/Chapter10.pdf
White DC. The histopathologic basis for functional decrement in late radiation injury in diverse organs. Cancer. 1976;37:1126-1143.
Cassady JR. Clinical radiation nephropathy. Int J Radiat Oncol Biol Phys. 1995;31:1249-1256.
Haycock GB. Development of glomerular filtration and tubular reabsortion in the human fetus and newborn. Br J Urol. 1998;81(2):33-38.
Mañalic R, Reyes L, Herrera M, et al. Relationship between weight at birth and the number and size of renal glomeruli in humans: a histomorphometric study. Kidney Int. 2000;58:770-773.
Dawson LA, Kavanagh BD, Paulino AC, et al. Radiation-associated kidney injury. Int J Radiat Oncol Biol Phys. 2010;76:S108-S115.
Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109-122.
Cheng J, Schultheiss T, Wong J. Impact of drug therapy, radiation dose and dose rate on renal toxicity following bone marrow transplantation. Int J Radiat Oncol Biol Phys. 2008;71:1436-1443.
Termuhlen AM, Tersak JM, Liu Q, et al. Twenty-five year follow-up of childhood Wilms tumor: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2011;57(7):1210-1216.
Sasso G, Greco N, Murino P, Sasso FS. Late toxicity in Wilms tumor patients treated with radiotherapy at 15 years of median f-up. J Pediatr Hematol Oncol. 2010;32:e264-e267.
Dávila Fajardo R, Seravalli E, Ruebe C, et al. Improved target coverage while simultaneous-integrated-sparing of kidney and liver by VMAT in children undergoing whole-abdomen irradiation for Wilms tumour. Pediatr Blood Cancer. 2016;63:S89-S89.
Jenwei Chen MJ, Raposo Leao C, Campos Pereira Simoes R, et al. Kidney-sparing whole abdominal irradiation in Wilms tumor: potential advantages of VMAT technique. Pediatr Blood Cancer. 2020;67:e28223.
Dieffenbach BV, Liu Q, Murphy AJ, et al. Late-onset kidney failure in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Eur J Cancer. 2021;155:216-226.
Green DM, Wang M, Krasin M, et al. Kidney function after treatment for childhood cancer: a report from the St. Jude Lifetime Cohort Study. J Am Soc Nephrol. 2021;32(4):983-993.
Lameire NH, Flombaum CD, Moreau D, et al. Acute renal failure in cancer patients. Ann Med. 2005;37(1):13-25.
Wilson CL, Liu W, Chemaitilly W, et al. Body composition, metabolic health and functional impairment among adults treated for abdominal and pelvic tumors during childhood. Cancer Epidemiol Biomarkers Prev. 2020;29(9):1750-1758.